Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: Implications for chronic fatigue syndrome and cancer

Brain, Behavior, and Immunity

Volumn 19, Issue 2, 2005, Pages 91-103

  Glaser, Ronald ^a,b,c   Padgett, David A ^a,b,c   Litsky, Monica L ^b   Baiocchi, Robert A ^a,c   Yang, Eric V ^a,b   Chen, Min ^b   Yeh, Peir En ^b   Klimas, Nancy G ^d   Marshall, Gailen D ^e   Whiteside, Theresa ^f,g   Herberman, Ronald ^f   Kiecolt Glaser, Janice ^b   Williams, Marshall V ^a,c  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Cancer; Chronic fatigue syndrome; dUTPase; EBV; Immune dysregulation; Stress; Viral latency

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; VIRUS ENZYME;

BODY MASS; BODY TEMPERATURE; CANCER; CELL DIVISION; CHRONIC FATIGUE SYNDROME; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOLYSIS; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; ILLNESS BEHAVIOR; IMMUNOREGULATION; IN VITRO STUDY; LATENT VIRUS INFECTION; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; STEADY STATE; STRESS; VIRUS REPLICATION;

ANIMALS; EPSTEIN-BARR VIRUS INFECTIONS; FATIGUE SYNDROME, CHRONIC; HUMANS; NEOPLASMS; STRESS; VIRUS LATENCY;

EID: 19944433429     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2004.09.001     Document Type: Conference Paper

References (102)

1. D.V. Ablashi, H.B. Eastman, C.B. Owen, M.M. Roman, J. Friedman, J.B. Zabriskie, D.L. Peterson, G.R. Pearson, and J.E. Whitman Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients J. Clin. Virol.: The Official Publication of the Pan American Society for Clinical Virology 16 3 2000 179 191
2. R. Ader, D.L. Felten, and N. Cohen Psychoneuroimmunology 1991 Academic Press San Diego, CA
3. M.D. Addario, A. Ahmad, A. Morgan, and J. Menezes Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-α gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases J. Mol. Biol. 298 2000 765 778
4. H. Anisman, and Z. Merali Cytokines, stress and depressive illness: brain-immune interactions Ann. Med. 35 2003 2 11
5. S.M. Ansell, C.-Y. Li, R.V. Lloyd, and R.L. Phyliky Epstein-Barr virus infection in Richter's transformation Am. J. Hematol. 60 1999 99 104
6. R. Baer, A.T. Bankier, M.D. Biggin, P.L. Deininger, P.J. Farrell, T.J. Gibson, G. Hatfull, G.S. Hudson, S.C. Satchwell, and C. Seguin DNA sequence and expression of the B95-8 Epstein-Barr virus genome Nature 310 5974 1984 207 211
7. E. Barker, S.F. Fujimura, M.B. Fadem, A.L. Landay, and J.A. Levy Immunologic abnormalities associated with chronic fatigue syndrome Clin. Infect. Dis. 18 Suppl. 1 1994 S136 S141
8. G. Bauer Induction of Epstein-Barr virus early antigens by corticosteroids: inhibition by TPA and retinoic acid Int. J. Cancer 31 1983 291 295
9. L. Borish, K. Schmaling, J.D. DiClementi, J. Streib, J. Negri, and J.F. Jones Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables J. Allergy Clin. Immunol. 102 2 1998 222 230
10. D. Buchwald, R.L. Ashley, T. Pearlman, P. Kith, and A.L. Komaroff Viral serologies in patients with chronic fatigue and chronic fatigue syndrome J. Med. Virol. 50 1 1996 25 30
11. D. Buckwald, J.L. Sullivan, and A.L. Komaroff Frequency of chronic active Epstein-Barr virus infection in a general medical practice JAMA 257 1987 2303 2307
12. D.R. Budiani, S. Hutahaean, S.M. Haryana, M. Soesatyo, and W. Sosroseno Interleukin-10 levels in Epstein-Barr virus-associated nasopharyngeal carcinoma J. Microbiol. Immunol. Infect. 35 4 2002 265 268
13. J.T. Cacioppo, J.K. Kiecolt-Glaser, W.B. Malarkey, B.F. Laskowski, L.A. Rozlog, K. Poehlmann, M.H. Burleson, and R. Glaser Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus Horm. Behav. 42 2002 32 41
14. J.G. Cannon, J.B. Angel, R.W. Ball, L.W. Abad, L. Fagiolo, and A.L. Komaroff Acute phase responses and cytokine secretion in chronic fatigue syndrome J. Clin. Immunol. 19 6 1999 414 421
15. B.D. Carter, W.G. Kronenberger, J.F. Edwards, G.S. Marshall, K.N. Schikler, and D.L. Causey Psychological symptoms of chronic fatigue and juvenile rheumatoid arthritis Pediatrics 103 5, part 1 1999 975 979
16. Y-C. Cheng, Y.Y. Chen, R. Glaser, and W. Henle Frequency and levels of antibodies to Epstein-Barr virus specific DNase are elevated in patients with nasopharyngeal carcinoma Proc. Natl. Acad. Sci. USA 77 10 1980 6162 6165
17. Y.-C. Cheng, J.Y. Chen, P.J. Hoffman, and R. Glaser Studies on the activity of DNase associated with the replication of the Epstein-Barr virus Virology 100 1980 334 338
18. R. Dantzer Cytokine-induced sickness behavior: mechanisms and implications Ann. NY Acad. Sci. 933 2001 222 234
19. M. de Turenne-Tessier, T. Ooka, A. Calender, G. de The, and J. Daillie Relationship between nasopharyngeal carcinoma and high antibody titers to Epstein-Barr virus-specific thymidine kinase Int. J. Cancer 43 1989 45 48
20. R. de Waal Malefy, J. Abrams, B. Bennett, C.G. Figdor, and J.E. de Vries Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J. Exp. Med. 174 1991 1209 1220
21. D. Di Luca, M. Zorzenon, P. Mirandola, R. Colle, G.A. Botta, and E. Cassai Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome J. Clin. Microbiol. 33 6 1995 1660 1661
22. D.F. Dukers, P. Meij, M.B. Vervoort, W. Vos, R.J. Scheper, C.J. Meijer, E. Bloemena, and J.M. Middeldorp Direct immunosuppressive effects of EBV-encoded latent membrane protein 1 J. Immunol. 165 2 2000 663 670
23. D. Emilie, R. Touitou, M. Raphael, M. Peuchmaur, O. Devergnee, D. Rea, J. Coumbraras, M.-C. Crevon, L. Edelman, I. Joab, and P. Galanaud In vivo production of interleukin-10 by malignant cells in AIDS lymphomas Eur. J. Immunol. 22 11 1992 2937 2942
24. B.A. Esterling, M.H. Antoni, M. Kumar, and N. Schneiderman Emotional repression, stress disclosure responses, and Epstein-Barr viral capsid antigen titers Psychosom. Med. 52 4 1990 397 410
25. B.A. Esterling, M.H. Antoni, N. Schneiderman, C.S. Carver, A. LaPerriere, G. Ironson, N.G. Klimas, and M.A. Fletcher Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and human herpesvirus type-6 in HIV-infected and at-risk gay men Psychosom. Med. 54 3 1992 354 371
26. L. Fayad, M.J. Keating, J.M. Reuben, S. O'Brien, B-N. Lee, S. Lerner, and R. Kurzrock Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome Blood 97 1 2001 256 263
27. J. Fleischmann, E. Kremmer, J.S. Greenspan, F.A. Grasser, and G. Niedobitek Expression of viral and human dUTPase in Epstein-Barr virus-associated diseases J. Med. Virol. 68 2002 568 573
28. T.R. Gerrity, J. Bates, D.S. Bell, G. Chrousos, G. Furst, T. Hedrick, B. Hurwitz, R.W. Kula, S.M. Levin, R.C. Moore, and R. Schondorf Chronic fatigue syndrome: what role does the autonomic nervous system play in the pathophysiology of this complex illness? Neuroimmunomodulation 10 2002 134 141
29. R. Glaser, T. Ogino, J Zimmerman Jr., and F. Rapp Thymidine kinase activity in Burkitt lymphoblastoid somatic cell hybrids after induction of the EB virus Proc. Soc. Exp. Biol. Med. 142 1973 1059 1062
30. R. Glaser, E.C. Strain, K. Tarr, J.E. Holliday, R.L. Donnerberg, and J.K. Kiecolt-Glaser Changes in Epstein-Barr virus antibody titers associated with aging Proc. Soc. Exp. Biol. Med. 179 1985 352 355
31. R. Glaser, J. Rice, J. Sheridan, R. Fertel, J. Stout, C. Speicher, D. Pinsky, M. Kotur, A. Post, and M. Beck Stress-related immune suppression: health implications Brain Behav. Immun. 1 1 1987 7 20
32. R. Glaser, G.R. Pearson, J.F. Jones, J. Hillhouse, S. Kennedy, H.Y. Mao, and J.K. Kiecolt-Glaser Stress-related activation of Epstein-Barr virus Brain Behav. Immun. 5 2 1991 219 232
33. R. Glaser, G.R. Pearson, R.H. Bonneau, B.A. Esterling, C. Atkinson, and J.K. Kiecolt-Glaser Stress and the memory T-cell response to the Epstein-Barr virus in healthy medical students Health Psychol. 12 1993 435 442
34. R. Glaser, and J.K. Kiecolt-Glaser Stress-associated immune modulation and its implications for reactivation of latent herpesviruses R. Glaser J. Jones Human Herpesvirus Infections 1994 Marcel Dekker New York 245 270
35. R. Glaser, D.K. Pearl, J.K. Kiecolt-Glaser, and W.B. Malarkey Plasma cortisol levels and reactivation of latent Epstein-Barr virus in response to examination stress Psychoneuroendocrinology 19 8 1994 765 771
36. R. Glaser, L.A. Kutz, R.C. MacCallum, and W.B. Malarkey Hormonal modulation of Epstein-Barr virus Replication Neuroendocrinol. 52 1995 356 361
37. R. Glaser, and J.K. Kiecolt-Glaser Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome Am. J. Med. 105 3A 1998 35S 42S
38. S. Gupta, S. Aggarwal, D. See, and A. Starr Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome J. Psychol. Res. 31 1 1997 149 156
39. W.C. Hellinger, T.F. Smith, R.E. Van Scoy, P.G. Spitzer, P. Forgacs, and R.S. Edson Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen JAMA 260 7 1988 971 973
40. G. Henle, W. Henle, and G. Klein Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus infected cells Int. J. Cancer 8 1971 272 282
41. W. Henle, J.H.C. Ho, G. Henle, and H.C. Kwan Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases and long term survivors J. Natl. Cancer Inst. 51 1973 361 369
42. B.E. Henry, R. Glaser, J. Hewetson, and D. O'Collaghan Expression of altered ribonucleotide reductase activity associated with the replication of the Epstein-Barr virus Virology 89 1978 262 271
43. G.P. Holmes, J.E. Kaplan, J.A. Stewart, B. Hunt, P.F. Pinsky, and L.B. Schonberger A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA 257 17 1987 2297 2302
44. M. Hummel, A. Zhang, S. Yan, I. Deplaen, P. Golia, T. Varghese, G. Thomas, and M.I. Abecassis Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation of latency J. Virol. 75 10 2001 4814 4822
45. J.H. Joncas, and M. Leyritz The effect of hydrocortisone and bromodeoxyuridine (BUdR) on the Epstein-Barr herpes virus in human lymphoblastoid cell lines Rev. Can. Biol. 33 1974 135 147
46. J.F. Jones, C.G. Ray, L.L. Minnich, M.J. Hicks, R. Kibler, and D.O. Lucas Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies Ann. Intern. Med. 102 1 1985 1 7
47. J.F. Jones, M. Williams, R.T. Schooley, C. Robinson, and R. Glaser Antibodies to Epstein-Barr virus specific DNase and DNA polymerase in the chronic fatigue syndrome Arch. Intern. Med. 148 9 1988 1957 1960
48. H. Kanno, N. Naka, Y. Yasunaga, K. Luchi, S. Yamauchi, M. Hashimoto, and K. Aozasa Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma. possible role in the development of overt lymphoma in immunocompetent hosts Am. J. Pathol. 150 1 1997 349 357
49. V.P. Khatri, and M.A. Caliguiri A review of the association between interleukin-10 and human B-cell malignancies Cancer Immunol. Immunother. 46 1998 239 244
50. N.G. Klimas, F.R. Salvator, R. Morgan, and M.A. Fletcher Immunologic abnormalities in chronic fatigue syndrome J. Clin. Microbiol. 28 6 1990 1403 1410
51. D.M. Koelle, S Barcy, M.-L. Huang, R.L. Ashley, L. Corey, J. Zeh, S. Ashton, and D. Buchwald Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome Clin. Infect. Dis. 35 2002 518 525
52. A.L. Komaroff The biology of chronic fatigue syndrome Am. J. Med. 108 2000 169 171
53. G.R. Krueger, U. Klueppelberg, A. Hoffman, and D.V. Ablashi Clinical correlates of infection with human herpesvirus-6 In Vivo 8 1994 457 485
54. G.R. Krueger, B. Koch, A. Hoffmann, J. Rojo, M.E. Brandt, G. Wang, and L.M. Buja Dynamics of chronic active herpesvirus-6 infection in patients with chronic fatigue syndrome: data acquisition for computer modeling In Vivo (Athens, Greece) 15 6 2001 461 465
55. R. Lai, S. O'Brien, T. Maushouri, A. Rogers, H. Kantarjian, M. Keating, and M. Albitar Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia Cancer 95 5 2002 1071 1075
56. M.-Y. Liu, W.-M. Cou, L. Nutter, M.-M. Hsu, and J.-Y. Chen Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma J. Med. Virol. 28 1989 101 105
57. S.K. Lutgendorf, M.H. Antoni, M.H. Kumar, and N. Schneiderman Changes in cognitive coping strategies predict EBV-antibody titre change following a stressor disclosure induction J. Psychosomatic Res. 38 1 1994 63 78
58. I.T. Magrath, P.A. Pizzo, L. Novikovs, and A.S. Levine Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids Virology 97 1979 477 481
59. S.F. Maier, and L.R. Watkins Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition Psychol. Rev. 105 1998 83 107
60. L.E. Mathes, R.G. Olsen, L.C. Hebebrand, E.A. Hoover, J.P. Schaller, P.W. Adams, and W.S. Nichols Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein from feline leukemia virus Cancer Res. 39 3 1979 950 955
61. A.C. Mawle, R. Nisenbaum, J.G. Dobbins, H.E. Gary, J.A. Stewart, M. Reyes, L. Steele, D.S. Schmid, and W.C. Reeves Seroepidemiology of chronic fatigue syndrome: a case-control study Clin. Infect. Dis. 21 6 1995 1386 1389
62. A.C. Mawle, R. Nisenbaum, J.G. Dobbins, H.E. Gary Jr., J.A. Stewart, M. Reyes, L. Steele, D.S. Schmid, and W.C. Reeves Immune responses associated with chronic fatigue syndrome: a case-control study J. Infect. Dis. 175 1997 136 141
63. S.K. Mehta, D.L. Pierson, H. Cooley, R. Dubow, and D. Lugg Epstein-Barr virus reactivation associated with diminished cell-mediated immunity in antarctic expeditioners J. Med. Virol. 61 2000 235 240
64. S.K. Mehta, R.P. Stowe, A.H. Feiveson, S.K. Tyring, and D.L. Pierson Reactivation and shedding of cytomegalovirus in astronauts during spaceflight J. Infect. Dis. 182 6 2000 1761 1764
65. R. Miller, R. Glaser, and F. Rapp Studies of an Epstein-Barr virus-induced DNA polymerase Virology 76 1977 494 502
66. K.W. Moore, A. O'Garra, R. De Waal Maleyt, P. Viera, and T.R. Mosmann Interleukin-10 Annu. Rev. Immunol. 11 1993 165 190
67. T.R. Mosmann Properties and functions of interleukin-10 Adv. Immunol. 56 1994 1 26
68. M.P.N. Nair, R. Pottathil, E.P. Heimer, and S.A. Schwartz Immuno-regulatory activities of human immunodeficiency virus (HIV proteins): effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes Proc. Natl. Acad. Sci. USA 85 1988 6498 6502
69. B.H. Natelson, N. Ye, D.E. Moul, F.J. Jenkins, D.A. Oren, W.N. Tapp, and Y.C. Cheng High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness J. Med. Virol. 42 1 1994 42 46
70. B.H. Natelson Chronic fatigue syndrome JAMA 285 20 2001 2557 2559
71. B.H. Natelson, M.H. Haghighi, and N.M. Ponzio Evidence for the presence of immune dysfunction in chronic fatigue syndrome Clin. Diagnostic Lab. Immun. 9 4 2002 747 752
72. B.H. Natelson, and L. Gudrun A status report on chronic fatigue syndrome Environ. Health Perspect. 110 Suppl. 4 2002 673 677
73. L.A. O'Neill Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily Curr. Top. Microbiol. Immunol. 270 2002 47 61
74. Padgett, D.A., Hotchkiss, A.K., Pyter, L.M., Nelson, R.J., Yang, E., Yeh, P-E., Litsky, M., Williams, M., Glaser, R., 2004. Epstein-Barr virus-encoded dUTPase modulates immune function and induces sickness behavior in mice. J. Med. Virol 74, 442-448
75. R. Patarca, N.G. Klimas, S. Lutgendorf, M. Antoni, and M.A. Fletcher Dysregulated expression of tumor necrosis factor in the chronic fatigue immune dysfunction syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression Clin. Infect. Dis. 18 1994 S147 S153
76. R. Patarca, N.G. Klimas, M.N. Garcia, H. Pons, and M.A. Fletcher Dysregulated expression of soluble immune mediator receptors in a subset of patients with chronic fatigue syndrome: categorization of patients by immune status J. Chronic Fatigue Syndrome 1 1995 79 94
77. R. Patarca, N.G. Klimas, D. Sandler, M.N. Garcia, and M.A. Fletcher Interindividual immune status variation patterns in patients with chronic fatigue syndrome: association with the tumor necrosis factor system and gender J. Chronic Fatigue Syndrome 2 1 1995 13 19
78. R. Patarca, T. Mark, M.A. Fletcher, and N. Klimas Review: immunology of chronic fatigue syndrome J. Chronic Fatigue Syndrome 6 2000 69 107
79. M. Patnaik, A.L. Komaroff, E. Conley, E.A. Ojo-Amaize, and J.B. Peter Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome J. Infect. Dis. 172 5 1995 1364 1367
80. D.A. Payne, S.K. Mehta, S.K. Tyring, R.P. Stowe, and D.L. Pierson Incidence of Epstein-Barr virus in astronaut saliva during spaceflight Aviation Space Environ. Med. 70 12 1999 1211 1213
81. S. Prosch, C.E. Wendt, P. Reinke, C. Priemer, M. Oppert, D.H. Kruger, H.D. Volk, and W.D. Docke A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation Virology 272 2 2000 357 365
82. C.R. Pugh, J.D. Johnson, D. Martin, J.W. Rudy, S.F. Maier, and L.R. Watkins Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments Brain Res. 861 1 2000 8 15
83. B.S. Rabin Stress, Immune Function, and Health: the Connection 1999 Wiley-Liss & Sons New York, NY
84. W.C. Reeves, A. Lloyd, S.D. Vernon, N. Klimas, L.A. Jason, G. Bleijenberg, B. Evengard, P.D. White, R. Nisenbaum, and E.R. Unger Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution BMC Health Serv. Res. (Electron. Resource) 3 1 2003 25
85. A. Reichenberg, R. Yirmiya, A. Schuld, T. Kraus, M. Haack, A. Morag, and T. Pollmacher Cytokine-associated emotional and cognitive disturbances in humans Arch. Gen. Psychiatry 58 2001 445 452
86. A.B. Rickinson, R.J. Murray, J. Brooks, H. Griffin, D.J. Moss, and M.G. Masucci T cell recognition of Epstein-Barr virus associated lymphomas Cancer Surv. 13 1992 53 80
87. T. Sairenji, K. Yamanishi, Y. Tachibana, G. Bertoni, and T. Kurata Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome Intervirology 38 5 1995 269 273
88. O. Sarid, O. Anson, A. Yaari, and M. Margalith Epstein-Barr virus specific salivary antibodies as related to stress caused by examinations J. Med. Virol. 64 2 2002 149 156
89. P. Sommer, E. Kremmer, S. Bier, S. Konig, P. Zalud, M. Zeppezauer, J.F. Jones, N. Mueller-Lantzsch, and F.A. Grasser Cloning and expression of the Epstein-Barr virus encoded dUTPase: patients with acute, reactivated or chronic virus infection develop antibodies against the enzyme J. Gen. Virol 77 Pt. 11 1996 2795 2805
90. R.P. Stowe, D.L. Pierson, D.L. Feeback, and A.D. Barrett Stress-induced reactivation of Epstein-Barr virus in astronauts Neuroimmunomodulation 8 2 2000 51 58
91. S.E. Straus, G. Tosato, G. Armstrong, T. Lawley, O.T. Preble, W. Henle, R. Davey, G. Pearson, J. Epstein, and I. Brus Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection Ann. Intern. Med. 102 1 1985 7 16
92. M.L. Subira, A. Castilla, M.P. Civeira, and J. Prieto Deficient display of CD3 on lymphocytes of patients with chronic fatigue syndrome J. Infect. Dis. 160 1 1989 165 166
93. K. Taga, H. Mostowski, and G. Tosato Human interleukin-10 can directly inhibit T-cell growth Blood 81 111 1993 2964 2971
94. E.M. Tan, K. Sugiura, and S. Gupta The case definition of chronic fatigue syndrome J. Clin. Immunol. 22 1 2002 8 12
95. J.E. Tanner, F. Diaz-Mitoma, C.M. Rooney, and C. Alfieri Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection J. Infect. Dis. 176 1997 1454 1461
96. T. Theorell, V. Blomkvist, G. Lindh, and B. Evengard Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis Psychosom. Med. 61 3 1999 304 310
97. U. Vollmer-Conna, A. Lloyd, I. Hickie, and D. Wakefield Chronic Fatigue Syndrome: an immunological perspective Aus. New Zealand J. Psychiatry 32 1998 523 527
98. P.D. White, J.M. Thomas, J. Amess, S.A. Grover, H.O. Kangro, and A.W. Clare The existence of a fatigue syndrome after glandular fever Psychol. Med. 25 5 1995 907 916
99. P.D. White The relationship between infection and fatigue J. Psychosom. Res. 43 4 1997 345 350
100. P.D. White, J.M. Thomas, J. Amess, D.H. Crawford, S.A. Grover, H.O. Kangro, and A.W. Clare Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever Br. J. Psychiatry; J. Mental Sci. 173 1998 475 481
101. P.D. White, J.M. Thomas, H.O. Kangro, W.D. Bruce-Jones, J. Amess, D.H. Crawford, S.A. Grover, and A.W. Clare Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis Lancet 358 9297 2001 1946 1954
102. M.V. Williams, J.E. Holliday, and R. Glaser Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells Virology 142 1985 326 333